Drug Type Small molecule drug |
Synonyms 力卓 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (30 Apr 2004), |
Regulation- |
Molecular FormulaC28H32N6 |
InChIKeyXOIOGKHKNQYULW-UHFFFAOYSA-N |
CAS Registry115103-15-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Tribendimidine | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ascariasis | China | 30 Apr 2004 | |
Hookworm Infections | China | 30 Apr 2004 |
Phase 2 | 130 | Placebo | (ttcmlgypux) = ygtptexamm zlldllsmoj (eenvxbalvk ) View more | - | 16 Aug 2019 | ||
(ttcmlgypux) = xfwveijhax zlldllsmoj (eenvxbalvk ) View more | |||||||
Not Applicable | 156 | iprvynhkpl(qjfolmpjav) = Adverse events caused by tribendimidine were significantly less than praziquantel fijtfxyisx (kpqksptjvy ) | - | 01 Aug 2014 | |||
Phase 2 | 125 | xleufsnzfd(noxbpyxiqw) = zfegpsmvcp winbgyzved (jmpaijakcl ) | - | 01 Feb 2011 | |||
Mefloquine-artesunate | xleufsnzfd(noxbpyxiqw) = pjjggwmjpp winbgyzved (jmpaijakcl ) |